Since 2013, we have been heavily investing in CRISPR/Cas9-based mouse model development, and have designed a unique offer, combining our:
- Expertise in model design
- Rigorous quality controls for mouse models
With the advantages of gene editing technologies, such as:
- Cost effectiveness
- Short development time
"We are applying CRISPR/Cas9 technology to create Knockouts and Knockins in outbred, and more fragile inbred genetic backgrounds such as C57BL/6."
You will benefit from:
- Three independent genetically modified lines
- Freedom to operate thanks to our unique IP portfolio, including a license from Broad Institute (MIT)
- Off-target measurement
- Short development time
CRISPR/Cas9-based mouse model development
Get in touch about
Let us know how we can help
Scientific excellence
From model design to experimental results
Tailor-made solutions adapted to scientific questions
Robust validation data on catalog models
Comprehensive dataset package
Generated with biopharma partners and in-house
Customer care
Scientific follow-up and advice along the project
Collaborative approach for problem solving and development of innovative models
Easy and fast access to models
Breeding facilities in US and Europe
Certified health status from professional breeders